Skip to Main Content
Back to News

Lobbying Update: $40,000 of CASTLE BIOSCIENCES INC. lobbying was just disclosed

None

$40,000 of CASTLE BIOSCIENCES INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Issues relating to Medicare coverage for laboratory diagnostic services."

You can find more data on corporate lobbying on Quiver Quantitative.

CSTL Insider Trading Activity

CSTL insiders have traded $CSTL stock on the open market 163 times in the past 6 months. Of those trades, 0 have been purchases and 163 have been sales.

Here’s a breakdown of recent trading of $CSTL stock by insiders over the last 6 months:

  • DEREK J MAETZOLD (Pres. & Chief Exec. Officer) has traded it 129 times. They made 0 purchases and 129 sales, selling 80,793 shares.
  • DANIEL BRADBURY has traded it 24 times. They made 0 purchases and 24 sales, selling 39,351 shares.
  • FRANK STOKES (Chief Financial Officer) has traded it 4 times. They made 0 purchases and 4 sales, selling 16,923 shares.
  • TOBIN W JUVENAL (Chief Commercial Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 6,607 shares.
  • KRISTEN M OELSCHLAGER (Chief Operating Officer) has traded it 4 times. They made 0 purchases and 4 sales, selling 18,821 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CSTL Hedge Fund Activity

We have seen 112 institutional investors add shares of CSTL stock to their portfolio, and 62 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles